GRAIL, Inc. (GRAL)
GRAL Stock Price Chart
Explore GRAIL, Inc. interactive price chart. Choose custom timeframes to analyze GRAL price movements and trends.
GRAL Company Profile
Discover essential business fundamentals and corporate details for GRAIL, Inc. (GRAL) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
12 Jun 2024
Employees
1.00K
Website
https://grail.comCEO
Robert P. Ragusa
Description
GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.
GRAL Financial Timeline
Browse a chronological timeline of GRAIL, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 19 Jan 2026
Upcoming earnings on 11 Nov 2025
EPS estimate is -$3.40, while revenue estimate is $33.83M.
Earnings released on 12 Aug 2025
EPS came in at -$3.18 falling short of the estimated -$3.14 by -1.27%, while revenue for the quarter reached $35.54M , beating expectations by +4.23%.
Earnings released on 13 May 2025
EPS came in at -$3.10 surpassing the estimated -$4.03 by +23.08%, while revenue for the quarter reached $31.84M , missing expectations by -9.55%.
Earnings released on 20 Feb 2025
EPS came in at -$1.86 surpassing the estimated -$4.41 by +57.82%, while revenue for the quarter reached $38.25M , beating expectations by +6.85%.
Earnings released on 12 Nov 2024
EPS came in at -$3.94 surpassing the estimated -$6.43 by +38.72%, while revenue for the quarter reached $28.65M , missing expectations by -16.71%.
Earnings released on 13 Aug 2024
EPS came in at -$5.30 , while revenue for the quarter reached $31.97M .
Earnings released on 31 Mar 2024
EPS came in at -$7.05 , while revenue for the quarter reached $26.72M .
Earnings released on 31 Dec 2023
EPS came in at -$0.18 , while revenue for the quarter reached $30.33M .
Earnings released on 30 Sept 2023
EPS came in at -$28.71 , while revenue for the quarter reached $20.72M .
Earnings released on 29 Jun 2023
EPS came in at -$6.22 , while revenue for the quarter reached $22.41M .
Earnings released on 2 Apr 2023
EPS came in at -$6.24 , while revenue for the quarter reached $19.64M .
Earnings released on 29 Sept 2020
EPS came in at -$0.58 .
GRAL Stock Performance
Access detailed GRAL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.